SBP-101

SBP-101 (polyamine analog) · Panbela Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SBP-101, covering 2018-04-20 to 2024-11-06. Get the full timeline:

Most recent: Clinical Trial Update: Study of Nab-Paclitaxel and Gemcitabine With or Without SBP-101 in Pancreatic Cancer [Phase 2, Phase 3]